Timothy J Scannell insider trades: NovoCure (NVCR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timothy reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | NVCR | ↓ Sell | 2,945 | $15.77 | $46K | Direct | Jun 3, 2026 (1d) |
| Jun 3, 2025 | NVCR | ↓ Sell | 999 | $17.32 | $17K | Direct | Jun 4, 2025 (1d) |
| Sep 10, 2024 | PODD | ↓ Sell | 5,000 | $225.84 | $1.1M | Direct | Sep 11, 2024 (1d) |
| Jun 10, 2024 | PODD | ↓ Sell | 7,000 | $190.51 | $1.3M | Direct | Jun 11, 2024 (1d) |
| Jun 4, 2024 | NVCR | ↓ Sell | 964 | $23.89 | $23K | Direct | Jun 6, 2024 (2d) |
| May 28, 2024 | PODD | ↓ Sell | 3,300 | $180.90 | $597K | Direct | May 29, 2024 (1d) |
| Nov 23, 2020 | SYK | ↓ Sell | 5,000 | $232.61 | $1.2M | Direct | Nov 24, 2020 (1d) |
| Nov 18, 2019 | SYK | ↓ Sell | 4,666 | $206.28 | $963K | Direct | Nov 19, 2019 (1d) |
| Oct 16, 2019 | SYK | ↓ Sell | 4,666 | $214.50 | $1.0M | Direct | Oct 17, 2019 (1d) |
| Sep 17, 2019 | SYK | ↓ Sell | 4,666 | $218.51 | $1.0M | Direct | Sep 18, 2019 (1d) |
| Aug 16, 2019 | SYK | ↓ Sell | 4,666 | $217.07 | $1.0M | Direct | Aug 19, 2019 (3d) |
| Jul 16, 2019 | SYK | ↓ Sell | 4,666 | $205.88 | $961K | Direct | Jul 17, 2019 (1d) |
| Jun 18, 2019 | SYK | ↓ Sell | 4,666 | $197.68 | $922K | Direct | Jun 19, 2019 (1d) |
| May 16, 2019 | SYK | ↓ Sell | 4,666 | $186.71 | $871K | Direct | May 17, 2019 (1d) |
| Apr 16, 2019 | SYK | ↓ Sell | 4,666 | $192.40 | $898K | Direct | Apr 17, 2019 (1d) |
| Mar 18, 2019 | SYK | ↓ Sell | 4,666 | $193.28 | $902K | Direct | Mar 19, 2019 (1d) |
| Feb 19, 2019 | SYK | ↓ Sell | 4,666 | $186.25 | $869K | Direct | Feb 20, 2019 (1d) |
| Jan 16, 2019 | SYK | ↓ Sell | 5,282 | $163.50 | $864K | Direct | Jan 17, 2019 (1d) |
| Dec 18, 2018 | SYK | ↓ Sell | 9,332 | $161.60 | $1.5M | Direct | Dec 19, 2018 (1d) |
| May 2, 2017 | SYK | ↓ Sell | 13,322 | $135.89 | $1.8M | Direct | May 3, 2017 (1d) |
| May 31, 2016 | SYK | ↓ Sell | 9,945 | $110.72 | $1.1M | Direct | Jun 2, 2016 (2d) |
| May 15, 2015 | PODD | ↑ Buy | 3,500 | $27.05 | $95K | Direct | May 18, 2015 (3d) |
| Feb 4, 2014 | SYK | ↓ Sell | 7,500 | $76.84 | $576K | Direct | Feb 4, 2014 (0d) |
| Feb 5, 2013 | SYK | ↓ Sell | 1,200 | $62.79 | $75K | Direct | Feb 7, 2013 (2d) |
| Feb 23, 2011 | SYK | ↓ Sell | 3,288 | $61.89 | $204K | Direct | Feb 24, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NVCR insiders
Open-market trades in the last 12 months
About Timothy J Scannell's insider trades
Timothy J Scannell is an insider at NovoCure (NVCR). Since Feb 23, 2011, Timothy has reported 1 open-market purchase worth $95K and 24 sales worth $19.9M on SEC Form 4. In the last 12 months: 1 sale ($46K).
Their filings also include grants and awards (47 filings), option exercises (34 filings), shares withheld for taxes (25 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.